Distinct phenotypes of human prostate cancer cells associate with different adaptation to hypoxia and pro-inflammatory gene expression

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ravenna, Linda ^a,b   Principessa, Lorenzo ^c   Verdina, Alessandra ^b   Salvatori, Luisa ^a,b   Russo, Matteo Antonio ^d   Petrangeli, Elisa ^a,c,d  

^a CNR   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; HYPOXIA INDUCIBLE FACTOR 3ALPHA; MESSENGER RNA; PARTHENOLIDE; HIF1A PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADAPTATION; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DU145 CELL LINE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; INFLAMMATION; LNCAP CELL LINE; METASTASIS; PC3 CELL LINE; PROSTATE CANCER CELL LINE; PROTEIN LOCALIZATION; RNA TRANSCRIPTION; CELL HYPOXIA; GENE EXPRESSION REGULATION; MALE; METABOLISM; PHENOTYPE; PROSTATE TUMOR; TUMOR CELL LINE;

ADAPTATION, PHYSIOLOGICAL; CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NF-KAPPA B; PHENOTYPE; PROSTATIC NEOPLASMS;

EID: 84900406956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096250     Document Type: Article

References (46)

1. Salvatori L, Caporuscio F, Verdina A, Starace G, Crispi S, et al. (2012) Cell-tocell signaling influences the fate of prostate cancer stem cells and their potential to generate more aggressive tumors. PLoS ONE 7: e31467.
2. Sharma P, Chinaranagari S, Patel D, Carey J, Chaudhary J (2012) Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer. Cancer Med 1: 176-186.
3. Tafani M, Russo A, Di Vito M, Sale P, Pellegrini L, et al. (2010) Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment. Cancer Sci 101: 1014-1023.
4. Tafani M, Di Vito M, Frati A, Pellegrini L, De Santis E, et al. (2011) Proinflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma. J Neuroinflammation doi: 10.1186/1742-2094-8-32.
5. Burrows N, Babur M, Resch J, Williams KJ, Brabant G (2011) Hypoxiainducible factor in thyroid carcinoma. J Tyroid Res doi: 10.4061/2011/762905.
6. Chien CW, Lin SC, Lai YY, Lin BW, Lin SC, et al. (2008) Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer. Clin Cancer Res 14: 8043-8051.
7. Matsuo Y, Ding Q, Desaki R, Maemura K, Mataki Y, et al. (2014) Hypoxia inducible factor-1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study. J Hepatobiliary Pancreat Sci. 21: 105-112.
8. Marignol L, Coffey M, Lawler M, Hollywood D (2008) Hypoxia in prostate cancer: a powerful shield against tumor destruction? Cancer Treat Rev 34: 313-327.
9. Stewart GD, Ross JA, McLaren DB, Parker CC, Habib FK, et al. (2009) The relevance of a hypoxic tumor microenvironment in prostate cancer. BJU Int 105: 8-13.
10. Dai Y, Bae K, Siemann DW (2011) Impact of hypoxia on the metastatic potential of human prostate cancer cells. Int J Radiat Oncol Biol Phys 81: 521-528.
11. Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408.
12. Semenza GL (2008) Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life 60: 591-597
13. Pasanen A, Heikkilä M, Rautavuoma K, Hirsilä M, Kivirikko KI, et al. (2010) Hypoxia-inducible factor (HIF)-3alpha is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2. Int J Biochem Cell Biol 42: 1189-1200.
14. Ratcliffe PJ (2007) HIF-1 and HIF-2: working alone or together in hypoxia? J Clin Invest 117: 862-865.
15. Keith B, Johnson RS, Simon MC (2012) HIF1α and HIF2α: sibling rivalry in hypoxic tumor growth and progression. Nat Rev Cancer 12: 9-22.
16. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, et al. (2007) Inflammation in prostate carcinogenesis. Nature 7: 256-269. (Pubitemid 46486616)
17. Gueron G, De Siervi A, Vazquez E (2012) Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behaviour. Prostate Cancer Prostatic Dis 15: 213-221.
18. Perkins ND (2012) The diverse and complex roles of NF-kB subunits in cancer. Nat Rev Cancer 12: 121-132.
19. Taylor CT, Cummins EP (2009) The role of NF-kB in hypoxia-induced gene expression. Ann N Y Acad Sci 1177: 178-184.
20. Fitzpatrick SF, Tambuwala MM, Bruning U, Schaible B, Scholz CC, et al. (2011) An intact canonical NF-kB pathway is required for inflammatory gene expression in response to hypoxia. J Immunol 186: 1091: 1096.
21. Bruning U, Fitzpatrick SF, Frank T, Birtwistle M, Taylor CT, et al. (2012) NFkB and HIF display synergistic behaviour. Cell Mol Life Sci 69: 1319-1329.
22. van Uden P, Kenneth NS, Rocha S (2008) Regulation of hypoxia-inducible factor-1a by NF-kB. Biochem J 412: 477-484.
23. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, et al. (2008) NF-kB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453: 807-811. (Pubitemid 351793778)
24. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, et al. (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-kB activity. J Exp Med 201: 105-115. (Pubitemid 40130088)
25. De Santis E, Di Vito M, Perrone GA, Mari E, Osti M et al. (2013) Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells. Biomed Pharmacother 67: 7-16.
26. Ravenna L, Sale P, Di Vito M, Russo A, Salvatori L, et al.(2009) Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma. The Prostate 69: 1245-1255.
27. Rane JK, Pellacani D, Maitland NJ (2012) Advanced prostate cancer-a case for adjuvant differentiation therapy. Nat Rev Urol 9: 595-602.
28. Webber MM, Bello D, Quader S (1997) Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines. Prostate 30: 58-64. (Pubitemid 27053542)
29. Dalrymple S, Antony L, Xu Y, Uzgare AR, Arnold JT, et al. (2005) Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells. Cancer Res 65: 9269-9279. (Pubitemid 41507993)
30. Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, et al.(2005) RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J Biol Chem 280: 36529-36540. (Pubitemid 41633927)
31. van Leenders GJLH, Aalders TW, Hulsbergen-van de Kaa CA, Ruiter DJ, et al. (2001) Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol 195: 563-570. (Pubitemid 34030794)
32. Patra N, De U, Kim TH, Lee YJ, Ahn MY, et al. (2013) A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells. Biomed Pharmacoter 67: 407-415.
33. Akashi T, Koizumi K, Tsuneyama K, Saiki I, Takano Y, et al. (2008) Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci 99: 539-542. (Pubitemid 351228571)
34. Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, et al. (2009) Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res 2009 7: 1745-1755.
35. Ferrando M, Gueron G, Elguero B, Giudice J, Salles A, et al. (2011) Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer. Angiogenesis 14: 467-479.
36. Uchida T, Rossignol F, Matthay MA, Mounier R, Couette S, et al. (2004) Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1α and HIF-2 a expression in lung epithelial cells: implication of natural antisense HIF-1α. J Biol Chem 279: 14871-14878.
37. Li QF, Wang XR, Yang YW, Lin H (2006) Hypoxia upregulates hypoxia inducible factor (HIF)-3α expression in lung epithelial cells: characterization and comparison with HIF-1α Cell Res 16: 548-558.
38. Tanaka T, Wiesener M, Bernhardt W, Eckardt KU, Warnecke C (2009) The human HIF (hypoxia-inducible factor)-3α gene is a HIF-1 target gene and may modulate hypoxic gene induction. Biochem J 424: 143-151.
39. Mahapatra S, Klee EW, Young CY, Sun Z, Jimenez RE, et al. (2012) Global methylation profiling for risk prediction of prostate cancer. Clin Cancer Res 18: 2882-2895.
40. Di Donato JA, Mercurio F, Karin M (2012) NF-kB and the link between inflammation and cancer. Immunological Reviews 246: 379-400.
41. Wong CP, Bray TM, Ho E (2009) induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages. Cancer Lett 276: 38-46.
42. Hehner SP, Hofmann TG, Dröge W, Schmitz ML (1999) The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kB by targeting the I kB kinase complex. J Immunol 163: 5617-5623.
43. Mathema VB, Koh YS, Thakuri BC, Sillanpää M (2012) Parthenolide, a sesquiterpene lactone, express multiple anti-cancer and anti-inflammatory activities. Inflammation 35: 560-565.
44. Tafani M, Pucci B, Russo A, Schito L, Pellegrini L, et al. (2013) Modulators of HIF1α and NFkB in cancer treatment: is it a rational approach for controlling malignant progression? Frontiers in Pharmacol 4: 1-12.
45. Rojas A, Figueroa H, Morales E (2010) Fueling inflammation at tumor microenvironment: the role of multiligand/rage axis. Carcinogenesis 31: 334-341.
46. Tafani M, Schito L, Pellegrini L, Villanova L, Marfe G, et al. (2011) Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-kB. Carcinogenesis 32: 1167-1175.